Jump to content

Genedata Screener for Mechanistic Analysis - SLAS2022

This video shows how mechanistic analysis in Genedata Screener improves drug screening success with early inclusion of assays, which provide mechanistic and kinetic information on drug-target engagement. Mechanistic assays performed at scale on automation platforms can be rapidly analyzed for routine characterization of thousands of analytes. Genedata Screener enables unmatched throughput by automating the data modelling and decision-making process for time-dependent target-enzyme binding analysis.

Request Resource

By submitting my data, I give consent to the collection, processing and use of my personal data in accordance with the Genedata privacy policy